Early Neurovascular Adaptations in Aging Women
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexFemale
Age18-70
SponsorUniversity of Missouri-Columbia
About this trial
Our goal is to enhance our understanding of early vascular adaptations in aging women with an emphasis on the sympathetic nervous system.
Eligibility criteria
Qualifiers
Assigned female at birth (AFAB)
18-70 years of age
Disqualifiers
Assigned male at birth (AMAB)
Pregnancy, breastfeeding
Body mass index ≥30 kg/m2
Taking medications known to affect metabolic, autonomic, and/or respiratory function
Trial design
Treatments tested in this trial
- Norepinephrine
- Isoproterenol
- Acetylcholine
- Nitroprusside
- Estrogen
Treatment groups
64 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Missouri-Columbia
Lead sponsor
American Heart Association
Collaborator
Source ClinicalTrials.gov